4D Molecular Therapeutics Statistics

Total Valuation

FDMT has a market cap or net worth of $611.35 million. The enterprise value is $261.38 million.

Market Cap	611.35M
Enterprise Value	261.38M

Important Dates

The last earnings date was Monday, November 10, 2025, before market open.

Earnings Date	Nov 10, 2025
Ex-Dividend Date	n/a

Share Statistics

FDMT has 57.14 million shares outstanding. The number of shares has increased by 10.07% in one year.

Current Share Class	57.14M
Shares Outstanding	57.14M
Shares Change (YoY)	+10.07%
Shares Change (QoQ)	+0.36%
Owned by Insiders (%)	3.23%
Owned by Institutions (%)	49.98%
Float	42.92M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5,094.54
Forward PS	18.06
PB Ratio	1.36
P/TBV Ratio	1.66
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2,178.17
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.42, with a Debt / Equity ratio of 0.06.

Current Ratio	8.42
Quick Ratio	8.22
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -45.38% and return on invested capital (ROIC) is -29.32%.

Return on Equity (ROE)	-45.38%
Return on Assets (ROA)	-27.64%
Return on Invested Capital (ROIC)	-29.32%
Return on Capital Employed (ROCE)	-58.75%
Revenue Per Employee	$529
Profits Per Employee	-$921,485
Employee Count	227
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +49.86% in the last 52 weeks. The beta is 2.95, so FDMT's price volatility has been higher than the market average.

Beta (5Y)	2.95
52-Week Price Change	+49.86%
50-Day Moving Average	10.32
200-Day Moving Average	6.00
Relative Strength Index (RSI)	50.62
Average Volume (20 Days)	872,372

Short Selling Information

The latest short interest is 5.19 million, so 9.08% of the outstanding shares have been sold short.

Short Interest	5.19M
Short Previous Month	4.27M
Short % of Shares Out	9.08%
Short % of Float	12.09%
Short Ratio (days to cover)	5.28

Income Statement

In the last 12 months, FDMT had revenue of $120,000 and -$209.18 million in losses. Loss per share was -$3.74.

Revenue	120,000
Gross Profit	-177.96M
Operating Income	-227.28M
Pretax Income	-209.18M
Net Income	-209.18M
EBITDA	-222.71M
EBIT	-227.28M
Loss Per Share	-$3.74

Full Income Statement

Balance Sheet

The company has $305.06 million in cash and $22.26 million in debt, giving a net cash position of $349.97 million or $6.13 per share.

Cash & Cash Equivalents	305.06M
Total Debt	22.26M
Net Cash	349.97M
Net Cash Per Share	$6.13
Equity (Book Value)	368.98M
Book Value Per Share	7.89
Working Capital	275.27M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$183.50 million and capital expenditures -$1.56 million, giving a free cash flow of -$185.05 million.

Operating Cash Flow	-183.50M
Capital Expenditures	-1.56M
Free Cash Flow	-185.05M
FCF Per Share	-$3.24

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-189,399.17%
Pretax Margin	-174,314.17%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FDMT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.07%
Shareholder Yield	-10.07%
Earnings Yield	-34.22%
FCF Yield	-30.27%

Analyst Forecast

The average price target for FDMT is $30.33, which is 183.46% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$30.33
Price Target Difference	183.46%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	337.15%
EPS Growth Forecast (5Y)	-0.70%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FDMT has an Altman Z-Score of -0.55 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.55
Piotroski F-Score	2